HAYDEN DONALD J JR
Insider CIK 1202285 · INSM Director · VTAE Director · FOLD Director · RGNX Director · THRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| THRX Theseus Pharmaceuticals, I | D To issuer deriv | 2024-02-14 | 2024-02-14 | 3,250 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | U Tender | 2024-02-14 | 2024-02-14 | 10,000 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2023-06-13 | 2023-06-13 | 3,250 | — | $0 | 3,250 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2023-06-13 | 2023-06-13 | 19,500 | — | $0 | 19,500 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-12-30 | 2023-01-03 | 9,900 | $5.00 | $49.5K | 10,000 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-12-29 | 2023-01-03 | 100 | $5.00 | $500 | 100 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2022-05-17 | 2022-05-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2020-02-10 | 2020-02-12 | 24,800 | — | $0 | 129,100 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2020-02-10 | 2020-02-12 | 24,800 | $0.85 | $21.1K | 24,800 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2020-02-10 | 2020-02-12 | 24,800 | $50.11 | $1.24M | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2020-02-05 | 2020-02-07 | 2,000 | — | $0 | 153,900 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2020-02-05 | 2020-02-07 | 2,000 | $50.00 | $100.0K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2020-02-05 | 2020-02-07 | 2,000 | $0.85 | $1.7K | 2,000 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2020-01-17 | 2020-01-21 | 3,200 | — | $0 | 155,900 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2020-01-17 | 2020-01-21 | 3,200 | $0.85 | $2.7K | 3,200 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2020-01-17 | 2020-01-21 | 3,200 | $50.01 | $160.0K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2020-01-14 | 2020-01-16 | 30,000 | — | $0 | 159,100 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2020-01-14 | 2020-01-16 | 30,000 | $45.60 | $1.37M | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2020-01-14 | 2020-01-16 | 30,000 | $0.85 | $25.5K | 30,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2019-05-31 | 2019-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INSM INSMED Inc | M Exercise deriv | 2019-04-09 | 2019-04-11 | 6,286 | — | $0 | 3,714 | SEC↗ |
| INSM INSMED Inc | M Exercise | 2019-04-09 | 2019-04-11 | 6,286 | $3.03 | $19.0K | 68,483 | SEC↗ |
| INSM INSMED Inc | S Sale | 2019-04-09 | 2019-04-11 | 6,286 | $32.99 | $207.4K | 62,197 | SEC↗ |
| INSM INSMED Inc | M Exercise deriv | 2019-02-22 | 2019-02-26 | 14,900 | — | $0 | 10,100 | SEC↗ |
| INSM INSMED Inc | S Sale | 2019-02-22 | 2019-02-26 | 14,900 | $28.08 | $418.4K | 62,197 | SEC↗ |
| INSM INSMED Inc | M Exercise | 2019-02-22 | 2019-02-26 | 14,900 | $3.03 | $45.1K | 77,097 | SEC↗ |
| INSM INSMED Inc | M Exercise deriv | 2019-02-15 | 2019-02-27 | 100 | — | $0 | 24,900 | SEC↗ |
| INSM INSMED Inc | S Sale | 2019-02-15 | 2019-02-27 | 100 | $27.90 | $2.8K | 62,197 | SEC↗ |
| INSM INSMED Inc | M Exercise | 2019-02-15 | 2019-02-27 | 100 | $3.03 | $303 | 62,297 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2018-06-07 | 2018-06-11 | 8,912 | — | $0 | 8,912 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2018-06-07 | 2018-06-11 | 3,081 | — | $0 | 8,895 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-06-05 | 2018-06-05 | 14,900 | — | $0 | 189,100 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-06-05 | 2018-06-05 | 14,900 | $55.01 | $819.6K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-06-05 | 2018-06-05 | 14,900 | $0.85 | $12.7K | 14,900 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-06-01 | 2018-06-05 | 100 | — | $0 | 204,000 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-06-01 | 2018-06-05 | 100 | $0.85 | $85 | 100 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-06-01 | 2018-06-05 | 100 | $55.00 | $5.5K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2018-05-25 | 2018-05-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-05-15 | 2018-05-16 | 9,847 | — | $0 | 204,100 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-05-15 | 2018-05-16 | 9,847 | $0.85 | $8.4K | 9,847 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-05-15 | 2018-05-16 | 9,847 | $50.06 | $492.9K | 0 | SEC↗ |
| INSM INSMED Inc | A Award | 2018-05-15 | 2018-05-17 | 6,066 | — | $0 | 62,197 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-05-14 | 2018-05-16 | 5,153 | — | $0 | 213,947 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-05-14 | 2018-05-16 | 5,153 | $0.85 | $4.4K | 5,153 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-05-14 | 2018-05-16 | 5,153 | $50.04 | $257.9K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-05-09 | 2018-05-11 | 15,000 | — | $0 | 219,100 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-05-09 | 2018-05-11 | 15,000 | $0.85 | $12.8K | 15,000 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-05-09 | 2018-05-11 | 15,000 | $45.00 | $675.0K | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2018-01-02 | 2018-01-04 | 10,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2018-01-02 | 2018-01-04 | 10,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise | 2018-01-02 | 2018-01-04 | 20,000 | $15.00 | $300.0K | 25,814 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | S Sale | 2018-01-02 | 2018-01-04 | 20,000 | $15.00 | $300.0K | 5,814 | SEC↗ |
| INSM INSMED Inc | M Exercise deriv | 2017-11-14 | 2017-11-16 | 15,000 | — | $0 | 25,000 | SEC↗ |
| INSM INSMED Inc | S Sale | 2017-11-14 | 2017-11-16 | 15,000 | $32.50 | $487.5K | 56,131 | SEC↗ |
| INSM INSMED Inc | M Exercise | 2017-11-14 | 2017-11-16 | 15,000 | $3.03 | $45.5K | 71,131 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2017-10-11 | 2017-10-13 | 20,000 | — | $0 | 234,100 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2017-10-11 | 2017-10-13 | 20,000 | $0.85 | $17.0K | 20,000 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2017-10-11 | 2017-10-13 | 20,000 | $34.95 | $699.0K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2017-09-27 | 2017-09-29 | 20,000 | — | $0 | 254,100 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2017-09-27 | 2017-09-29 | 20,000 | $32.45 | $649.0K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2017-09-27 | 2017-09-29 | 20,000 | $0.85 | $17.0K | 20,000 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2017-09-18 | 2017-09-19 | 20,000 | — | $0 | 274,100 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2017-09-18 | 2017-09-19 | 20,000 | $0.85 | $17.0K | 20,000 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2017-09-18 | 2017-09-19 | 20,000 | $29.95 | $599.0K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2017-09-15 | 2017-09-19 | 20,000 | — | $0 | 294,100 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2017-09-15 | 2017-09-19 | 20,000 | $27.45 | $549.0K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2017-09-15 | 2017-09-19 | 20,000 | $0.85 | $17.0K | 20,000 | SEC↗ |
| INSM INSMED Inc | M Exercise deriv | 2017-09-07 | 2017-09-07 | 15,000 | — | $0 | 40,000 | SEC↗ |
| INSM INSMED Inc | S Sale | 2017-09-07 | 2017-09-07 | 15,000 | $30.00 | $450.0K | 56,131 | SEC↗ |
| INSM INSMED Inc | M Exercise | 2017-09-07 | 2017-09-07 | 15,000 | $3.03 | $45.5K | 71,131 | SEC↗ |
| INSM INSMED Inc | M Exercise deriv | 2017-09-05 | 2017-09-07 | 15,000 | — | $0 | 70,000 | SEC↗ |
| INSM INSMED Inc | M Exercise deriv | 2017-09-05 | 2017-09-07 | 15,000 | — | $0 | 55,000 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2017-09-05 | 2017-09-07 | 20,000 | — | $0 | 314,100 | SEC↗ |
| INSM INSMED Inc | M Exercise | 2017-09-05 | 2017-09-07 | 15,000 | $3.03 | $45.5K | 71,131 | SEC↗ |
| INSM INSMED Inc | M Exercise | 2017-09-05 | 2017-09-07 | 15,000 | $3.03 | $45.5K | 71,131 | SEC↗ |
| INSM INSMED Inc | S Sale | 2017-09-05 | 2017-09-07 | 15,000 | $29.50 | $442.5K | 56,131 | SEC↗ |
| INSM INSMED Inc | S Sale | 2017-09-05 | 2017-09-07 | 15,000 | $29.50 | $442.5K | 56,131 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2017-09-05 | 2017-09-07 | 20,000 | $24.95 | $499.0K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2017-09-05 | 2017-09-07 | 20,000 | $0.85 | $17.0K | 20,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2017-06-13 | 2017-06-15 | 16,236 | — | $0 | 16,236 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2017-06-13 | 2017-06-15 | 5,814 | — | $0 | 5,814 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2017-05-24 | 2017-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| INSM INSMED Inc | A Award | 2017-05-17 | 2017-05-19 | 6,702 | — | $0 | 56,131 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2017-05-15 | 2017-05-17 | 8,599 | $19.04 | $163.7K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2017-05-08 | 2017-05-10 | 10,000 | $18.35 | $183.5K | 8,599 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2017-05-01 | 2017-05-03 | 20,000 | — | $0 | 251,382 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2017-05-01 | 2017-05-03 | 20,000 | $0.85 | $17.0K | 48,599 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2017-05-01 | 2017-05-03 | 4,738 | $21.34 | $101.1K | 43,861 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2017-05-01 | 2017-05-03 | 25,262 | $22.43 | $566.6K | 18,599 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2017-04-24 | 2017-04-26 | 10,000 | $20.98 | $209.8K | 28,599 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 10,000 | $11.38 | $113.8K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 10,000 | $8.57 | $85.7K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 17,000 | $13.00 | $221.0K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 18,182 | $15.71 | $285.6K | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2016-06-09 | 2016-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2016-06-01 | 2016-06-02 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2016-05-26 | 2016-05-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INSM INSMED Inc | A Award | 2016-05-19 | 2016-05-23 | 12,742 | — | $0 | 49,429 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2016-03-21 | 2016-03-21 | 1,935 | — | $0 | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2016-03-21 | 2016-03-21 | 14,195 | — | $0 | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2016-03-21 | 2016-03-21 | 1,935 | $3.45 | $6.7K | 1,935 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2016-03-21 | 2016-03-21 | 14,195 | $3.45 | $49.0K | 14,195 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | S Sale | 2016-03-21 | 2016-03-21 | 16,130 | $7.42 | $119.7K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2015-12-29 | 2015-12-30 | 16,130 | — | $0 | 1,935 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2015-12-29 | 2015-12-30 | 16,130 | $3.45 | $55.6K | 16,130 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | S Sale | 2015-12-29 | 2015-12-30 | 16,130 | $18.00 | $290.3K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | C Conversion deriv | 2015-09-22 | 2015-09-22 | 38,599 | — | $0 | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | C Conversion | 2015-09-22 | 2015-09-22 | 38,599 | — | $0 | 38,599 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2015-09-21 | 2015-09-22 | 16,130 | — | $0 | 18,065 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | S Sale | 2015-09-21 | 2015-09-22 | 16,130 | $17.00 | $274.2K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2015-09-21 | 2015-09-22 | 16,130 | $3.45 | $55.6K | 16,130 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2015-09-16 | 2015-09-17 | 5,208 | — | $0 | 5,208 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2015-09-16 | 2015-09-22 | 9,375 | — | $0 | 9,375 | SEC↗ |
| INSM INSMED Inc | S Sale | 2015-09-02 | 2015-09-03 | 9,252 | $24.08 | $222.8K | 36,687 | SEC↗ |
| INSM INSMED Inc | S Sale | 2015-09-01 | 2015-09-03 | 15,748 | $24.05 | $378.7K | 45,939 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2015-06-23 | 2015-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2015-06-23 | 2015-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2015-06-23 | 2015-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise deriv | 2015-06-23 | 2015-06-24 | 10,000 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | S Sale | 2015-06-23 | 2015-06-24 | 55,000 | $14.01 | $770.5K | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | M Exercise | 2015-06-23 | 2015-06-24 | 55,000 | $14.01 | $770.5K | 55,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2015-06-10 | 2015-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2015-05-28 | 2015-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise deriv | 2015-05-20 | 2015-05-22 | 20,000 | — | $0 | 14,195 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | M Exercise | 2015-05-20 | 2015-05-22 | 20,000 | $3.45 | $69.0K | 20,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | S Sale | 2015-05-20 | 2015-05-22 | 20,000 | $12.01 | $240.2K | 0 | SEC↗ |
| INSM INSMED Inc | A Award | 2015-01-08 | 2015-01-09 | 6,222 | — | $0 | 61,687 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2014-09-24 | 2014-09-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2014-06-12 | 2014-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INSM INSMED INC | M Exercise deriv | 2014-01-11 | 2014-01-14 | 8,955 | — | $0 | 0 | SEC↗ |
| INSM INSMED INC | M Exercise | 2014-01-11 | 2014-01-14 | 8,955 | — | $0 | 55,465 | SEC↗ |
| INSM INSMED INC | A Award | 2014-01-10 | 2014-01-14 | 2,928 | — | $0 | 46,510 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2013-06-13 | 2013-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INSM INSMED INC | M Exercise deriv | 2013-01-14 | 2013-01-15 | 15,988 | — | $0 | 0 | SEC↗ |
| INSM INSMED INC | M Exercise | 2013-01-14 | 2013-01-15 | 15,988 | — | $0 | 43,582 | SEC↗ |
| INSM INSMED INC | A Award deriv | 2013-01-11 | 2013-01-15 | 8,955 | — | $0 | 8,955 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2012-06-13 | 2012-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INSM INSMED INC | M Exercise deriv | 2012-01-23 | 2012-01-24 | 8,594 | — | $0 | 100,988 | SEC↗ |
| INSM INSMED INC | M Exercise | 2012-01-23 | 2012-01-24 | 8,594 | — | $0 | 27,594 | SEC↗ |
| INSM INSMED INC | A Award deriv | 2012-01-12 | 2012-01-13 | 15,988 | — | $0 | 109,582 | SEC↗ |